Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa; Refractories, Ceramics and Building materials Department, National Research Centre, 33El Bohouth St. (former El-Tahrir St.), Dokki, P.O.12622, Giza, Egypt.
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.
Int J Pharm. 2016 Jun 30;507(1-2):41-9. doi: 10.1016/j.ijpharm.2016.05.011. Epub 2016 May 3.
The aim of this study was to develop an in situ hybridized poly(vinyl alcohol)/calcium silicate (PVA/Ca2OSi) nanofibrous antibacterial wound dressing with calcium phosphate [Ca3(PO4)2] surface precipitation for enhanced bioactivity. This was achieved by hybridizing the antibacterial ions Zn(2+) and/or Ag(+) in a Ca2O4Si composite. The hybridization effect on the thermal behavior, physicochemical, morphological, and physicomechanical properties of the nanofibers was studied using Differential Scanning calorimetric (DSC), X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM) and Textural Analysis, respectively. In vitro bioactivity, biodegradation and pH variations of the nanofiber composite were evaluated in Simulated Body Fluid (SBF). The antibacterial activity was assessed against Staphylococcus aureus and Pseudomonas aeruginosa. Hybridization of Zn(2+) and/or Ag(+) into the PVA/Ca2O4Si nanofiber composite was confirmed by DSC, XRD and FTIR. The thickness of the nanofibers was dependent on the presence of Zn(2+) and Ag(+) as confirmed by SEM. The nanofibers displayed enhanced tensile strength (19-115.73MPa) compared to native PVA. Zn(2+) and/or Ag(+) hybridized nanofibers showed relatively enhanced in vitro bioactivity, biodegradation (90%) and antibacterial activity compared with the native PVA/Ca2O4Si nanofiber composite. Results of this study has shown that the PVA/Ca2O4Si composite hybridized with both Zn(2+) and Ag(+) may be promising as an antibacterial wound dressing with a nanofibrous archetype with enhanced bioactivity.
本研究旨在开发一种原位杂交聚(聚乙烯醇)/硅酸钙(PVA/Ca2OSi)纳米纤维抗菌伤口敷料,其表面沉淀磷酸钙[Ca3(PO4)2]以提高生物活性。这是通过在 Ca2O4Si 复合材料中杂化抗菌离子 Zn(2+)和/或 Ag(+)来实现的。使用差示扫描量热法(DSC)、X 射线衍射(XRD)、傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)和纹理分析分别研究了杂化对纳米纤维的热行为、物理化学、形态和物理机械性能的影响。在模拟体液(SBF)中评估了纳米纤维复合材料的体外生物活性、生物降解和 pH 变化。评估了对金黄色葡萄球菌和铜绿假单胞菌的抗菌活性。通过 DSC、XRD 和 FTIR 证实了 Zn(2+)和/或 Ag(+)的 PVA/Ca2O4Si 纳米纤维复合材料的杂化。SEM 证实了 Zn(2+)和 Ag(+)的存在对纳米纤维的厚度有影响。与天然 PVA 相比,纳米纤维显示出增强的拉伸强度(19-115.73MPa)。与天然 PVA/Ca2O4Si 纳米纤维复合材料相比,Zn(2+)和/或 Ag(+)杂化纳米纤维显示出相对增强的体外生物活性、生物降解(90%)和抗菌活性。本研究结果表明,PVA/Ca2O4Si 复合材料与 Zn(2+)和 Ag(+)的杂化可能是一种很有前途的具有增强生物活性的纳米纤维原型抗菌伤口敷料。